Carey Fineman Ziter syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Carey-Fineman-Ziter syndrome | |
|---|---|
| Synonyms | |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Facial weakness, myopathy, Pierre Robin sequence, scoliosis, delayed motor development |
| Complications | N/A |
| Onset | |
| Duration | |
| Types | |
| Causes | Mutations in the MYMK gene |
| Risks | |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | |
| Prevention | |
| Treatment | Supportive care, physical therapy, speech therapy |
| Medication | |
| Prognosis | |
| Frequency | Very rare |
| Deaths | |
Carey Fineman Ziter syndrome is a rare congenital disorder characterized by a combination of distinctive facial features, intellectual disability, and physical abnormalities. The syndrome was first described in 1982 by Dr. David Carey, Dr. Michael Fineman, and Dr. Robert Ziter.
Symptoms and Signs[edit]
The most common features of Carey Fineman Ziter syndrome include microcephaly (small head size), hypotonia (low muscle tone), myopathy (muscle weakness), ptosis (drooping of the upper eyelid), and distinctive facial features such as a high forehead, long face, and prominent chin. Intellectual disability is also common, and can range from mild to severe. Other features can include feeding difficulties, respiratory problems, and skeletal abnormalities.
Causes[edit]
Carey Fineman Ziter syndrome is caused by mutations in the MYMK gene. This gene provides instructions for making a protein that is involved in the development and function of muscles. Mutations in the MYMK gene disrupt the normal development and function of muscles, leading to the characteristic features of Carey Fineman Ziter syndrome.
Diagnosis[edit]
Diagnosis of Carey Fineman Ziter syndrome is based on the presence of characteristic clinical features. Genetic testing can confirm the diagnosis by identifying a mutation in the MYMK gene.
Treatment[edit]
There is currently no cure for Carey Fineman Ziter syndrome. Treatment is supportive and based on the signs and symptoms present in each individual. This can include physical therapy for muscle weakness, special education services for intellectual disability, and management of respiratory problems.
Prognosis[edit]
The prognosis for individuals with Carey Fineman Ziter syndrome varies depending on the severity of symptoms. Some individuals may have a normal lifespan, while others may have a shortened lifespan due to complications such as respiratory problems.
See Also[edit]
References[edit]
NIH genetic and rare disease info[edit]
Carey Fineman Ziter syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Carey Fineman Ziter syndrome
|
| Genetic disorders relating to deficiencies of transcription factor or coregulators | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Congenital Disorders | ||||||||
|---|---|---|---|---|---|---|---|---|
This congenital disorder related article is a stub.
|
| Syndromes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This syndrome related article is a stub.
|